Austrian Life Sciences 2024 to 2026: clinical studies
Programme note: Phase I and II
FFG (Austrian Research Promotion Agency)
Shared attributes
- Funding type: Grant
Programme recordNL-ZONMW-GGG
Funding Atlas programme
Geneesmiddelen VIMP 2026-1
Programme note: under Goed Gebruik Geneesmiddelen (GGG)
ZonMw
Funding typeGrantJurisdictionNetherlandsAreasAll therapeutic areas
Documented facts
Key facts
- Funder
- ZonMw
- Programme
- Geneesmiddelen VIMP 2026-1
- Programme note
- under Goed Gebruik Geneesmiddelen (GGG)
- Jurisdiction
- Netherlands
- Funding type
- Grant
- Therapeutic areas
- All therapeutic areas
Source-bound timeline
Supplied dates
These dates were recorded in the Atlas as of 3 October 2026. Confirm current timing with the funder.
- Final application cut-off (2:00 pm)